Should You Take 2 Plan B Pills If Overweight?

No reliable evidence supports taking two Plan B pills to compensate for higher body weight. The idea sounds logical: if blood levels of the active drug are lower in heavier people, a bigger dose should fix the gap. But the clinical trials that have tested exactly this approach found that doubling the dose did not meaningfully improve how well Plan B worked in women with obesity. The real story is more nuanced than a simple dose adjustment, and it matters because the alternatives that do work better at higher weights are often left out of the conversation entirely.

Why the Question Keeps Coming Up

Plan B’s active ingredient, levonorgestrel (LNG), is a synthetic hormone that works primarily by delaying or blocking ovulation. For ovulation to be disrupted, enough of the drug needs to reach the bloodstream quickly enough. And this is where body weight creates a real pharmacological problem.

Multiple studies have measured LNG blood levels in women across a range of body sizes after taking the standard 1.5 mg emergency dose. In one study, women with obesity had peak blood concentrations and overall drug exposure roughly 50% lower than women at a normal BMI.¹ Another found a similar pattern: peak LNG levels in women with obesity were about 5.6 ng/mL compared to 10.3 ng/mL in normal-weight women after the same dose.² A third trial confirmed the trend: both obese and extremely obese groups had peak concentrations around 10.5 ng/mL, compared to 16.2 ng/mL in normal-weight participants.³

The mechanism behind this drop is straightforward. LNG is a fat-soluble drug, and fat-soluble drugs tend to distribute more widely into adipose tissue in people with more body fat. That larger volume of distribution dilutes the drug’s concentration in the blood. Research on lipophilic drugs generally confirms that their distribution volume grows with obesity, and because the body clears them at roughly the same rate, it takes longer for any given dose to have its full effect.⁴ So the concern is real: less drug reaches the right place at the right time.

What the Pregnancy Data Show

Lower blood levels don’t automatically translate into clinical failure, but there is evidence that Plan B becomes less reliable at higher weights. A systematic review found roughly a fourfold increased risk of pregnancy among women with a BMI of 30 or above compared with women under 25 BMI after using LNG emergency contraception. That same analysis noted that at a body weight of about 80 kg (roughly 176 pounds), the estimated pregnancy rate after LNG rose above 6%, which is close to the expected pregnancy rate if no contraception were used at all. Below 75 kg, the rate stayed under 2%.⁵

A pooled analysis of four WHO studies found an even larger effect, with an odds ratio of about 8 for pregnancy in women with BMI over 30 compared to lower categories. But that striking number came with a significant asterisk: the result was driven largely by pregnancies at a single study site. When that site was excluded, obesity was no longer a statistically significant risk factor. The catch is that the remaining studies simply didn’t include enough women with obesity to rule out a substantial decrease in efficacy.⁶ The evidence points toward reduced effectiveness, but the exact magnitude is still debated. European regulators responded by updating product labeling to note reduced efficacy in heavier women, while the FDA reviewed the same data and decided the benefit still outweighed the risk at any weight.⁷

The Double-Dose Trials

Given the pharmacokinetic gap, researchers did exactly what you’d expect: they tested whether giving 3.0 mg of LNG (two pills instead of one) would restore effectiveness in women with obesity. The results were disappointing.

A randomized controlled trial enrolled 70 women with BMI of 30 or higher and measured the primary outcome that matters most for emergency contraception: whether the drug successfully blocked ovulation for at least five days after dosing. About half of the women in the single-dose group (51%) achieved this, compared to about 69% in the double-dose group. That difference sounds encouraging, but it was not statistically significant. The time to ovulation was also no different between groups.⁸ One of the pharmacokinetic studies cited earlier also measured LNG levels after single and double doses in women with obesity, and while the double dose did raise blood levels somewhat, those levels still didn’t match what normal-weight women achieved with a single pill.²

An even larger randomized trial tackled the same question from a different angle: it randomized 532 women weighing 80 kg or more to receive either a single LNG dose, a double LNG dose, or ulipristal acetate (a different emergency contraceptive pill). The pregnancy rates were so low across all three groups that the study was stopped early for futility. Only five pregnancies occurred total (one in the single-dose LNG group, one in the double-dose group, three in the ulipristal group), and none of these happened during the highest-risk ovulatory window.⁹ In practical terms, doubling the dose didn’t outperform the standard dose in either trial.

Why Doubling the Dose Doesn’t Simply Fix Things

The intuition that more drug equals more protection makes sense for many medications, but emergency contraception works on a narrow biological window. LNG’s main job is to delay or prevent the release of an egg. Once the hormonal cascade leading to ovulation is already underway, even a larger dose has limited power to interrupt it. A study tracking LNG use relative to timing of ovulation found that when women took the drug on the day of ovulation or later, there was essentially no protective effect: eight pregnancies occurred where roughly nine were expected without any contraception at all.¹⁰

This matters for the weight question because the problem may not be solely about drug concentration. If a woman happens to be very close to ovulating when she takes Plan B, the issue isn’t that there’s too little LNG in her blood. It’s that even a full dose won’t stop what’s already in motion. The variable that matters most is timing relative to the menstrual cycle, and that’s something no amount of extra pills can control.

There’s also a safety consideration. Doubling the dose of a hormonal medication without evidence of benefit introduces potential for more side effects, like nausea, headache, and disruption to the menstrual cycle, without a demonstrated payoff. No professional guideline currently recommends taking two Plan B pills for weight-related reasons. The one context in which doubling LNG is sometimes discussed is for women taking liver enzyme-inducing medications (certain anti-seizure drugs, for example), where drug clearance is genuinely accelerated by a different mechanism.¹¹ That’s a distinct situation from body-weight-related pharmacokinetics.

Alternatives That Actually Work Better at Higher Weights

If Plan B’s effectiveness drops at higher body weights, the practical question is what to use instead. Two alternatives have stronger evidence.

The copper intrauterine device (IUD) is the most effective form of emergency contraception at any weight. When inserted within five days of unprotected sex, it reduces the risk of pregnancy by more than 99%, and its effectiveness is not influenced by body weight at all. The copper IUD works by creating a hostile environment for sperm and preventing implantation, so it bypasses the ovulation-blocking mechanism that makes hormonal options weight-sensitive. The downside is access: you need a clinician to insert it, usually requiring a same-day or next-day appointment, which isn’t always feasible.

Ulipristal acetate, sold as ella in the United States, is a prescription-only emergency contraceptive pill that works through a different hormonal pathway. It’s a progesterone-receptor modulator rather than a progestin like LNG, and it remains effective closer to the moment of ovulation. While ulipristal’s pharmacokinetics are also affected by obesity, some evidence suggests it retains more of its effectiveness at higher weights than LNG does. In the large randomized trial described earlier, ulipristal didn’t outperform LNG in women over 80 kg, but the study was stopped for futility rather than showing equivalence in a definitive way.⁹ The main limitation is that ella requires a prescription in most countries, while Plan B is available over the counter.

What Pharmacists Often Don’t Tell You

A qualitative study of Canadian pharmacists found that while virtually all of them counseled patients about LNG emergency contraception and considered it important, they rarely brought up the copper IUD, even when the situation called for it. Specifically, pharmacists tended not to mention the IUD option when a patient had a BMI over 25 or when more than 72 hours had passed since unprotected sex, both scenarios where LNG’s effectiveness is reduced. Many pharmacists said they felt uncomfortable discussing body weight, and some felt conflicted between their healthcare role and their role as a retailer selling a product.¹²

This gap in counseling has real consequences. A woman who walks into a pharmacy weighing over 80 kg is likely to be handed Plan B without being told that a copper IUD or ella might be more appropriate. That’s not the pharmacist being negligent in most cases; it’s that the conversation around weight and contraception is awkward and the alternatives require a different care pathway (a prescription, a clinic visit). But it means you may need to advocate for yourself or call a clinic directly if you want the most effective option.

Cost is another barrier. In some health systems, LNG emergency contraception is cheaper and more accessible than ulipristal, and far more accessible than an IUD insertion on short notice. A comparative policy analysis found that including ulipristal in public formularies would be more equitable for women with lower incomes and higher body weights, but that coverage remains inconsistent.¹³ In the U.S., pharmacy access to emergency contraception varies: a survey found that three in four pharmacies stocked over-the-counter emergency contraception, but only about one in ten offered pharmacist-prescribed hormonal contraception of any kind.¹⁴

Timing Matters More Than Dose

Regardless of your weight, the single biggest factor determining whether any oral emergency contraceptive works is how quickly you take it after unprotected sex. Plan B is most effective in the first 24 hours and declines with every passing day. But even more than clock time, what really matters is where you are in your menstrual cycle. LNG works by delaying ovulation, so if ovulation hasn’t happened yet and the drug has time to act, it can prevent pregnancy effectively. If ovulation has already occurred or is imminent, LNG has little impact, as the data on day-of-ovulation use make clear.¹⁰

This is part of why the large trial in women over 80 kg saw so few pregnancies in any group: the study enrolled women throughout their cycle, and most were not in the narrow high-risk window where emergency contraception would actually be tested against a real pregnancy risk. The researchers noted that none of the five pregnancies occurred during the three days before or on the day of ovulation, the period when the biological stakes are highest.⁹ So some of the reassuring pregnancy rates in that trial may reflect favorable cycle timing rather than drug efficacy per se.

What to Actually Do

If you weigh over about 75 to 80 kg and need emergency contraception, here’s a practical framework based on what the evidence currently supports:

Copper IUD: The most effective option at any weight. If you can get an appointment within five days, this is the strongest choice. Call a clinic, urgent care, or Planned Parenthood the same day.
Ulipristal acetate (ella): Available by prescription and effective for up to five days. It requires a doctor’s visit or telehealth consultation, but it remains a better-studied option for higher weights than doubling Plan B.
Standard Plan B (1.5 mg LNG): Still worth taking if it’s all you can access. Even with reduced effectiveness at higher weights, it provides some protection and is better than nothing. Take it as soon as possible.
Double Plan B: Not currently recommended by any professional guideline. Clinical trials have not shown it improves outcomes in women with obesity. It costs twice as much and increases side effects without demonstrated benefit.

If you’re in a situation where Plan B is the only thing available, take the standard single dose quickly rather than spending time trying to find an alternative. Speed matters more than the specific product. But if you have a few hours and a phone, calling a clinic about a copper IUD or an ella prescription is worth the effort, especially if you weigh over 80 kg.

The Uncomfortable State of the Evidence

One of the frustrating realities about this topic is that the research base is thinner than you’d expect for a medication used by millions of people. The weight-and-efficacy question has been studied mostly through pooled analyses of older trials that weren’t designed to answer it, and the dedicated randomized trials are small. The ovulation-suppression trial enrolled 70 women total.⁸ The larger pregnancy-outcome trial enrolled 532 but had to stop early because pregnancy rates were too low in all groups to detect differences.⁹ That’s good news in one sense (pregnancy is rare even in heavier women using EC) but bad news for researchers trying to quantify exactly how much protection each option provides.

The pharmacokinetic data are clearer: blood levels of LNG are genuinely lower in women with higher body weight, and that gap persists even with a double dose. What remains less certain is how much that pharmacokinetic difference translates into real-world pregnancy risk, because emergency contraception studies are inherently difficult. You’re looking for a rare event (pregnancy in any given cycle) modified by an unpredictable variable (where the woman is in her cycle), and you’d need enormous sample sizes to get precise answers. Until those studies are done, the practical advice remains the same: use the most effective method you can access quickly, and don’t count on doubling Plan B to make up the difference.

1
PubMed. Pharmacokinetics of levonorgestrel and ulipristal acetate emergency contraception in women with normal and obese body mass index
2
PubMed Central. Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing
3
PubMed Central. Pharmacokinetics of the 1.5 mg levonorgestrel emergency contraceptive in women with normal, obese and extremely obese body mass index
4
British Journal of Clinical Pharmacology. Effect of lipophilicity on drug distribution and elimination: Influence of obesity
5
PubMed Central. Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review
6
PubMed Central. Effect of BMI and body weight on pregnancy rates with LNG as emergency contraception: analysis of four WHO HRP studies
7
PubMed Central. Plan B emergency contraceptive may be ineffective for heavier women
8
PubMed Central. Double Dosing Levonorgestrel-Based Emergency Contraception for Individuals With Obesity: A Randomized Controlled Trial
9
Contraception. Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel
10
PubMed. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation
11
Paediatrics & Child Health. Emergency contraception
12
PubMed. Beyond Plan B: A Qualitative Study of Canadian Pharmacists’ Emergency Contraception Counselling Practices
13
PubMed Central. Emergency contraception subsidy in Canada: a comparative policy analysis
14
PubMed. Pharmacist-Prescribed And Over-The-Counter Hormonal Contraception In Los Angeles County Retail Pharmacies